Form 4: Cardinal Health Executive Michelle Greene Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Michelle Greene, Chief Information Officer of Cardinal Health, reports the acquisition and disposal of company shares, including transactions related to vesting of restricted stock units and performance share units.

Summary

  • Michelle Greene, Chief Information Officer of Cardinal Health, filed a Form 4 detailing changes in beneficial ownership of Cardinal Health stock.
  • On August 15, 2024, shares were withheld to cover tax obligations related to the vesting of 2,682 restricted share units (RSUs) and 2,785 performance share units.
  • Also on August 15, 2024, 4,819 RSUs were granted, vesting in three equal annual installments starting August 15, 2025.
  • On August 16, 2024, additional shares were withheld to cover tax obligations related to the vesting of 3,466 RSUs.
  • On August 19, 2024, 4,000 shares were sold at a weighted average price of $108.85, with individual transactions ranging from $108.67 to $108.97.
  • Following these transactions, Greene directly owns 19,242 shares of Cardinal Health.

Sentiment

Score: 5

Explanation: The document is neutral, reporting standard stock transactions by an executive. There is no inherent positive or negative sentiment.

Positives

  • The grant of 4,819 RSUs indicates continued investment in the company's future by the executive.

Negatives

  • The sale of 4,000 shares, while potentially for personal financial management, could be interpreted negatively by some investors.

Risks

  • Executive stock sales can sometimes be perceived as a lack of confidence in the company's future performance, although this sale appears to be routine.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They are closely monitored by investors for insights into management's perspective on the company's valuation and future prospects. Form 4 filings are a standard part of regulatory compliance.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units (RSUs) to align management's interests with those of shareholders.
  • Vesting schedules for RSUs typically range from three to five years, with annual or quarterly vesting intervals.
  • Tax withholding practices related to vesting equity are standard across publicly traded companies.
  • Executive stock sales are common and can be influenced by various factors, including personal financial planning and diversification strategies.
  • Comparable companies such as McKesson and AmerisourceBergen also have executives who regularly report stock transactions via Form 4 filings.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders' perception of the company, depending on how they interpret the executive's stock sale.

Key Dates

DateDescription
08/15/2024Shares withheld for tax obligations related to vesting of RSUs and performance share units; Grant of 4,819 RSUs.
08/16/2024Shares withheld for tax obligations related to vesting of RSUs.
08/19/2024Sale of 4,000 shares at an average price of $108.85.
08/15/2025First vesting date for the RSUs granted on August 15, 2024.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.